Archives: Advantages


  • Durable, Cross-reactive, and Mucosal Immunity

    Durable, Cross-reactive, and Mucosal Immunity

    Our vaccine triggers both mucosal and systemic immune responses that are long-lasting and cross-reactive within virus families.  The mucosal immune responses are both local to the intestinal delivery site and distal, potentially providing protection across multiple mucosal surfaces, including the nose, the mouth, and the intestines.  Potent vaccine-induced antibodies were even induced in breast milk…

    Read More

  • Convenient Oral Administration

    Convenient Oral Administration

    Vaxart’s oral pill vaccine is designed for convenient, self-administration, eliminating the need for needles.  Our oral pill vaccine could help overcome needle-related hesitancy and could reduce healthcare infrastructure traditionally needed to administer needle-based vaccines, thereby offering the promise to improve accessibility and public health.

    Read More

  • State-of-the-art Recombinant Technology

    State-of-the-art Recombinant Technology

    Our oral pill vaccines eliminate injection site reactions, potentially leading to improved tolerability. Unlike some traditional immunizations, our vaccines do not contain live, replicating virus or animal products, which means they could offer an alternative to a broader range of individuals, including immunocompromised populations.

    Read More

  • Thermostable

    Thermostable

    Vaxart’s oral pill vaccines are designed to maintain their efficacy without the need for refrigeration, unlike many injectable vaccines that require complex, cold chain storage. This increased stability can make distribution easier and more cost-effective, especially in areas with limited infrastructure.

    Read More

  • Rapid Development

    Rapid Development

    Our modular, scalable, and standardized approach to vaccine development supports the rapid development of various vaccines against established targets as well as against new and emerging pathogens.

    Read More

  • Global Accessibility

    Global Accessibility

    A thermostable oral pill vaccine offers the potential for self-administration, empowering patients to manage their own immunizations. This easy-to-administer dosage form could significantly reduce healthcare costs, improve accessibility, and enhance distribution, particularly in remote or underserved areas.

    Read More